Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Tumor Exosome Profiling Market CAGR Outlook And Future Development
The tumor exosome profiling market size has seen rapid expansion in recent years. It is anticipated to increase from $1.13 billion in 2025 to $1.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.9%. The market’s historic growth can be attributed to factors such as the rising prevalence of cancer, continuous advancements in molecular biology techniques, the increasing adoption of liquid biopsy methods, a surge in research funding for oncology, and the growing demand for non-invasive diagnostic tools.
The tumor exosome profiling market size is projected for swift expansion over the next few years. It is anticipated to reach $2.49 billion by 2030, progressing at a compound annual growth rate (CAGR) of 17.1%. This growth during the forecast period can be attributed to the integration of AI and bioinformatics in exosome profiling, the development of personalized medicine solutions, the expansion of diagnostic laboratories, the adoption of high-throughput exosome analysis platforms, and the growth in cancer biomarker discovery. Significant trends expected during this period include liquid biopsy integration, high-throughput exosome analysis, automated sample preparation, multi-omics data profiling, and personalized cancer therapeutics.
Get A Free Sample Report With In-Depth Market Insights:
Tumor Exosome Profiling Market Demand Drivers: What’s Powering Industry Growth?
The expanding occurrence of cancer is anticipated to fuel the expansion of the tumor exosome profiling market in the future. Cancer encompasses a collection of illnesses marked by the unregulated proliferation and division of irregular cells, capable of invading adjacent tissues and disseminating throughout the body. The rising incidence of cancer stems from unwholesome lifestyles, such as inadequate diet, insufficient physical activity, smoking, and excessive intake of alcohol, all of which elevate the likelihood of contracting diverse forms of cancer. Tumor exosome profiling assists in combating cancer by facilitating early detection, tracking tumor advancement, and directing tailored treatment approaches via the examination of tumor-originated exosomes found in bodily fluids. For example, data from February 2024, provided by the World Health Organization, a Switzerland-based international entity focused on global health policy and public health endeavors, indicates that more than 35 million new cancer cases are projected for 2050, representing a 77% rise from the approximately 20 million cases recorded in 2022. Consequently, the increasing occurrence of cancer is a primary catalyst for the swift expansion of the tumor exosome profiling market.
Tumor Exosome Profiling Market Segments: Where Is Growth Concentrated?
The tumor exosome profiling market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software, Services
2) By Sample Type: Blood, Urine, Saliva, Other Sample Types
3) By Application: Cancer Diagnostics, Prognostics, Therapeutics, Research
4) By End-User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Other End-Users
Subsegments:
1) By Kits And Reagents: Isolation Kits, Detection Kits, Quantification Kits, Labeling Reagents, Antibodies
2) By Instruments: Flow Cytometers, Nanoparticle Tracking Analyzers, Ultracentrifuges, Microfluidic Devices, Polymerase Chain Reaction Machines (PCR) Machines
3) By Software: Data Analysis Software, Visualization Software, Bioinformatics Platforms, Statistical Modeling Software, Exosome Tracking Software
4) By Services: Sample Preparation Services, Exosome Isolation Services, Molecular Profiling Services, Data Analysis Services, Custom Assay Development Services
Tumor Exosome Profiling Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading enterprises within the tumor exosome profiling market are concentrating on developing advanced solutions, such as assays based on liquid biopsies of exosomes, to facilitate early cancer detection and personalized treatment monitoring. This type of assay functions as a blood test capable of identifying minute vesicles, called exosomes, released by tumor cells, thus enabling medical practitioners to pinpoint and supervise cancer without resorting to invasive tissue biopsies. For example, in June 2024, Mercy BioAnalytics Inc., a US-based biotechnology company, formed a partnership with University College London (UCL), a UK-based university, to introduce the Mercy Halo Ovarian Cancer Screening Test. This next-generation extracellular vesicle liquid biopsy is engineered to detect ovarian cancer in asymptomatic, postmenopausal women by identifying multiple co-localized cancer biomarkers found on individual tumor-derived vesicles using a low volume blood sample and a quantitative polymerase chain reaction (qPCR) based readout, delivering high sensitivity and specificity several years before clinical diagnosis.
Tumor Exosome Profiling Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the tumor exosome profiling market are Thermo Fisher Scientific Inc., Lonza Group Ltd., NanoFCM Inc., QIAGEN N.V., Bio-Techne Corporation, Miltenyi Biotec B.V. And Co. KG, Aethlon Medical Inc., Cusabio Technology LLC, Norgen Biotek Corp., Kimera Labs Inc, Diagenode Inc., Creative Biolabs Inc, Izon Science Ltd., System Biosciences LLC, Mercy Bioanalytics Inc, MtoZ Biolab, Capital Biosciences Inc., ExoCan Healthcare Technologies Private Limited, INOVIQ Ltd, Codiak BioSciences Inc.
View The Full Tumor Exosome Profiling Market Report:
Tumor Exosome Profiling Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the tumor exosome profiling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor exosome profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
